ARCH Venture Partners XIV, L.P.
CIK: 0002147717
Transaction Breakdown
Open Market Buys (P)1 (100.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ASPE
Aspen Neuroscience, Inc.
10% Owner
Discretionary Trading P&L
Holdings
About ARCH Venture Partners XIV, L.P.
ARCH Venture Partners XIV, L.P. (SEC CIK 0002147717) files insider reports with the SEC as 10% Owner of Aspen Neuroscience, Inc. (ASPE).
Signal8 holds 1 ownership filing by ARCH Venture Partners XIV, L.P., a Form 4, filed on Nov 2, 2026. Those filings report 1 transaction, the latest on Nov 2, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on ARCH Venture Partners XIV, L.P.'s filings is in CHICAGO, IL.
Recent filings by ARCH Venture Partners XIV, L.P.
- Nov 2, 2026: Open-market purchase of ASPE shares (Form 4, code P).
Other insiders filing for Aspen Neuroscience, Inc. (ASPE)
- ARCH Venture Fund X, L.P., 10% Owner
- Spaventa Andrew, Director
- Hasnain Faheem, Executive Chair
- ORBIMED ADVISORS LLC, Director
- Boerneke Jeffrey Lee, General Counsel and Secretary
- Daniel Thomas O, Director